NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 52 filers reported holding NEUROCRINE BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $125,000 | +278.8% | 123,545 | +261.8% | 0.00% | – |
| Q4 2020 | $33,000 | -54.8% | 34,152 | -55.1% | 0.00% | – |
| Q3 2020 | $73,000 | +711.1% | 76,128 | +907.0% | 0.00% | – |
| Q2 2020 | $9,000 | +28.6% | 7,560 | 0.0% | 0.00% | – |
| Q1 2020 | $7,000 | – | 7,560 | -100.0% | 0.00% | – |
| Q1 2019 | $0 | – | 18,991,000 | +72.6% | 0.00% | – |
| Q4 2018 | $0 | – | 11,000,000 | +606.0% | 0.00% | – |
| Q3 2018 | $0 | – | 1,558,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TENOR CAPITAL MANAGEMENT Co., L.P. | 45,447,000 | $60,497,000 | 1.31% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,366,000 | $5,924,000 | 0.54% |
| Aequim Alternative Investments LP | 7,609,000 | $10,088,000 | 0.43% |
| MACKAY SHIELDS LLC | 27,806,000 | $37,405,000 | 0.35% |
| Weiss Asset Management LP | 10,000,000 | $13,290,000 | 0.33% |
| WOLVERINE ASSET MANAGEMENT LLC | 13,230,000 | $17,541,000 | 0.13% |
| Polar Asset Management Partners Inc. | 7,500,000 | $9,942,000 | 0.10% |
| LORD, ABBETT & CO. LLC | 22,141,000 | $29,732,000 | 0.07% |
| Calamos Advisors LLC | 7,500,000 | $9,967,000 | 0.05% |
| D. E. Shaw & Co., Inc. | 39,270,000 | $52,046,000 | 0.04% |